Teva Pharmaceutical Industries Ltd
TEVA
Revenue
4.16B
▲345.00M▲9.03%
3 Months ChangeAssets
41.34B
▼-1.44B▼-3.35%
3 Months ChangeLiabilities
34.77B
▼-456.00M▼-1.29%
3 Months ChangeFree Cash Flow
6.00M
▲254.00M▲102.42%
3 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-07-31
Form 10-Q
ID: 0001193125-24-189924
2024-07-31
Form 8-K
ID: 0001171843-24-004270
2024-06-25
Form 8-K
ID: 0001193125-24-167489
2024-06-06
Form 8-K
ID: 0001193125-24-156043
2024-05-15
Form 8-K
ID: 0001193125-24-138936
2024-05-08
Form 10-Q
ID: 0001193125-24-134200
2024-05-08
Form 8-K
ID: 0001193125-24-133759
2024-04-18
Form 8-K
ID: 0001193125-24-100771
2024-01-31
Form 8-K
ID: 0001157523-24-000137
2023-11-09
Form 10-Q
ID: 0001193125-23-274495